Ruwan Y. Parakrama

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Jeffrey Chi · 1 shared paper, 2021 · strength 0.16
   • Paper The role of PARP inhibitors in BRCA mutated pancreatic cancer. DOI 10.1177/17562848211014818↗
2. Muhammad Wasif Saif · 1 shared paper, 2021 · strength 0.16
   • Paper The role of PARP inhibitors in BRCA mutated pancreatic cancer. DOI 10.1177/17562848211014818↗
3. Shamsher Ali Pasha · 1 shared paper, 2023 · strength 0.15
   • Paper Development of a Neoadjuvant Treatment Pathway to Standardize Pancreatic Cancer Care and Improve Outcomes Across a Larg… DOI 10.1101/2023.09.19.23295749↗
4. Lyudmyla Demyan · 1 shared paper, 2023 · strength 0.15
   • Paper Development of a Neoadjuvant Treatment Pathway to Standardize Pancreatic Cancer Care and Improve Outcomes Across a Larg… DOI 10.1101/2023.09.19.23295749↗
5. Leila T. Tchelebi · 1 shared paper, 2023 · strength 0.15
   • Paper Development of a Neoadjuvant Treatment Pathway to Standardize Pancreatic Cancer Care and Improve Outcomes Across a Larg… DOI 10.1101/2023.09.19.23295749↗
6. Oliver J. Standring · 1 shared paper, 2023 · strength 0.15
   • Paper Development of a Neoadjuvant Treatment Pathway to Standardize Pancreatic Cancer Care and Improve Outcomes Across a Larg… DOI 10.1101/2023.09.19.23295749↗
7. Joseph M. Herman · 1 shared paper, 2023 · strength 0.15
   • Paper Development of a Neoadjuvant Treatment Pathway to Standardize Pancreatic Cancer Care and Improve Outcomes Across a Larg… DOI 10.1101/2023.09.19.23295749↗
8. Daniel A. King · 1 shared paper, 2023 · strength 0.15
   • Paper Development of a Neoadjuvant Treatment Pathway to Standardize Pancreatic Cancer Care and Improve Outcomes Across a Larg… DOI 10.1101/2023.09.19.23295749↗
9. Matthew John Weiss · 1 shared paper, 2023 · strength 0.15
   • Paper Development of a Neoadjuvant Treatment Pathway to Standardize Pancreatic Cancer Care and Improve Outcomes Across a Larg… DOI 10.1101/2023.09.19.23295749↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.